Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The Purpose of A Multicenter, Randomized, Double-blind, Placebo-controlled to Evaluate the
Efficacy, Safety and Pharmacokinetics of N02RS1 600mg and 1,200mg per day in Patients With
acute and acute exacerbation of chronic bronchitis for 7 days.